Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

AZN Stock Latest News

Market News3 Best Stocks to Buy Now, 12/12/2024, According to Top Analysts

9d ago

AZN

EFX

PremiumThe Fly

AstraZeneca says 87.5% of Lynparza-treated patients alive at six years in trial

10d ago

AZN

MRK

PremiumThe Fly

AstraZeneca, Daiichi Sankyo announce BTD for datopotamab deruxtecan

12d ago

AZN

PremiumThe Fly

AstraZeneca reports ‘positive’ results from AMPLIFY Phase 3 trial

13d ago

AZN

PremiumThe Fly

AstraZeneca granted priority review for Imfinzi sBLA

15d ago

AZN

PremiumThe FlyAstraZeneca sBLA for Imfinzi granted Priority Review in MIBC

15d ago

AZN

AstraZeneca announces FDA approval for Imfinzi

Premium

The Fly

AstraZeneca announces FDA approval for Imfinzi

16d ago

AZN

AstraZeneca’s Imfinzi approved in U.S. as immunotherapy regimen for LS-SCLC

Premium

The Fly

AstraZeneca’s Imfinzi approved in U.S. as immunotherapy regimen for LS-SCLC

16d ago

AZN

PremiumThe Fly

AstraZeneca appoints Iskra Reic as Executive Vice President, International

17d ago

AZN

PremiumMarket News

AstraZeneca (AZN) Sees Its Cancer Drug Added to China’s Reimbursement List

23d ago

AZN

JNJ

PremiumThe Fly

AstraZeneca announces results from CAPItello-281 trial

26d ago

AZN

PremiumThe Fly

AstraZeneca’s Truqap combo demonstrated statistically significant improvement

26d ago

AZN

PremiumMarket NewsIonQ (IONQ) Stock Lacks Needed Catalysts

30d ago

AZN

AstraZeneca upgraded to Neutral from Sell at UBS

Premium

The Fly

AstraZeneca upgraded to Neutral from Sell at UBS

1M ago

AZN

AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg

Premium

The Fly

AstraZeneca price target lowered to EUR 140 from EUR 150 at Berenberg

1M ago

AZN

PremiumThe Fly

Grail tests first patient for TROPION-Lung12 Phase 3 study

1M ago

AZN

GRAL

PremiumThe Fly

Lunit announces collaboration with AstraZeneca to develop AI-powered tools

1M ago

AZN

PremiumThe Fly

AstraZeneca’s Tagrisso recommended for approval in EU by CHMP for certain NSCLC

1M ago

AZN

PremiumThe Fly

FDA Cellular, Tissue & Gene Therapies Advisory Committee holds virtual meeting

1M ago

AZN

PremiumThe FlySoros boosts stake in AstraZeneca, exits Apple position

1M ago

AstraZeneca put volume heavy and directionally bearish

Premium

The Fly

AstraZeneca put volume heavy and directionally bearish

1M ago

AZN

Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics

Premium

The Fly

Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics

1M ago

AZN

GSK

AZN Stock Latest News

Trending

Indices

Stocks

ETFs